Foamix Pharmaceuticals Ltd (FOMX)

[tdeck]

FOMX DD POST THE BASICS

Foamix Pharmaceuticals

http://www.foamix.com/

October 2019 Investor Presentation (A MUST READ)

http://www.foamix.com/static-files/c4fa5ee5-5991-4ba8-ac57-bb3c011483ee

Recent Significant Events

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

http://www.foamix.com/news-releases/news-release-details/foamix-announces-fda-acceptance-its-new-drug-application-fmx103

UPDATE -- Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers

http://www.foamix.com/news-releases/news-release-details/update-foamix-receives-fda-approval-amzeeqtm-topical-minocycline

Outstanding Shares: 61,003,927

Institutional/Fund 13G/13F Filers Latest SEC Edgar Filings
Had to go through the filings as no site seems to keep proper numbers, as the saying goes if want it done right do it yourself, so I did.

Perceptive Advisors/Joseph Edelman 11,203,881

OrbiMed Capital 5,195,330

Delaware Street Capital Master Fund 3,062,593

Meir Eini Holdings Ltd 3,015,024

Tamarkin Dov 2,930,783

Tamarkin Medical Innovations Ltd 2,751,447

Franklin Resources, Inc. 2,473,026

Axa 1,344,262

Sio Capital Management, LLC 1,295,669

Chizic Chaim 1,197,309

Sofinnova Ventures Inc 1,115,810

MILLENNIUM MANAGEMENT LLC 832,025

DAFNA Capital Management LLC 808,000

Senvest Management, LLC 755,998

Stonepine Capital Management, LLC 651,211

BlackRock Inc. 544,896

DLD Asset Management, LP 525,000

Baker Bros. Advisors 498,189

FIRST MANHATTAN CO 432,200

KNOTT DAVID M 371,046

Renaissance Technologies LLC 323,600

Tekla Capital Management LLC 300,781

Bank of New York Mellon Corp 277,096

Eversept Partners, Llc 263,390

BAILLIE GIFFORD & CO 219,400

DEUTSCHE BANK AG\ 189,511

ARK Investment Management LLC 146,745

WELLS FARGO & COMPANY/MN 130,202

Short interest which is no doubt higher today as the stock has been heavily shorted by those looking for FOMX to not receive FDA Approval, to bad, so sad shorts approval was granted

Shares sold short as of 09/30/2019 4,216,898

Analyst coverage and price targets, which one would think shall be updated in the coming days/weeks with the approval and acceptance of their second application for FOX3 the treatment of Moderate-to-Severe Papulopustular Rosacea with a Pdufa date of June 20, 2020 8 months from now.

All 4 with a buy recommendation with a price target average of $15.25

Bank OF America Securities

Cantor Fitzgerald

Cowen & Company

HC Wainwright

Will have a detailed DD post tomorrow outlaying the companies plans moving forward and a timeline for subsequent events.

Will have links etc so that one can do their DD with greater ease.